Loading clinical trials...
Loading clinical trials...
This study will evaluate the use of acetaminophen in preterm infants when a patent ductus arteriosus (PDA) is of concern. We will perform two simultaneous prospective observational studies over a 3 year period. The first will be of infants with clinically significant PDAs beyond 14 days of life who are medically treated with acetaminophen as a means to avoid surgical ligation, and the second will be of infants who received acetaminophen for a PDA closure during the first 2 weeks of life as a result of ibuprofen, the current standard of care in our NICU, contraindication due to medical status.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Albany Medical Center
Albany, New York, United States
Start Date
August 1, 2017
Primary Completion Date
June 30, 2019
Completion Date
June 30, 2019
Last Updated
January 13, 2020
11
ACTUAL participants
Acetaminophen
DRUG
Lead Sponsor
Albany Medical College
NCT06658496
NCT06298344
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06601114